openPR Logo
Press release

Irritable Bowel Syndrome Treatment Market to Hit $2,012 Mn by 2026

04-09-2020 01:11 PM CET | Health & Medicine

Press release from: Allied Market Research

Irritable Bowel Syndrome Treatment Market

Irritable Bowel Syndrome Treatment Market

Irritable Bowel Syndrome Treatment Market size was valued at $ 1,071 million in 2018, and is projected to reach $2,012 million by 2026, growing at a CAGR of 8.2% from 2019 to 2026.

Irritable bowel syndrome is a gastrointestinal tract (GT) illness with the symptoms such as alteration of bowel habits and severe abdominal pain. Usually, the digested food passes through the gastrointestinal tract (GT) and the movement of food is due to intestinal muscle contraction.

The irritable bowel syndrome hinders natural movements of that muscle; thus, food material cannot pass through the digestive tract and may result in abdominal pain, diarrhea, mucus in the stool, constipation, bloating & gas, and cramping. The Centers for Disease Control and Prevention (CDC) suggested that nearly 3 million people in the U.S. were reported being treated with irritable bowel syndrome in 2015. The irritable bowel syndrome can be treated by making changes by proper medication, making changes in daily diet, and reducing stress.

Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/6313

The major factors that boost the growth of the global irritable bowel syndrome treatment market are adoption of sedentary lifestyle, rise in level of stress, unhealthy diet, rise in geriatric population, surge in prevalence of gastrointestinal diseases and disorders such as alteration of bowel habit, & abdominal pain, increase in awareness programs for irritable bowel syndrome treatment, and launches of various developed pipeline drugs for the irritable bowel syndrome treatment during the forecast period.

Moreover, increase in prevalence of irritable bowel syndrome in female is expected to further drive the growth of the global irritable bowel treatment market. However, lack of specific treatment which treat all the symptoms of this disorder, and high competition among the key players related to pricing are expected to restrain the irritable bowel syndrome treatment market growth.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6313

Key Findings of the Study:
o Based on type, the IBS with diarrhea (IBS-D) segment held 47.76% share in the global market in 2018.
o Based on product, the rifaximin segment accounted for the largest irritable bowel syndrome treatment market share in 2018 and is expected to remain dominant throughout the forecast period.
o Based on end user, the drug stores & retail pharmacies segment held 54.01% share in the global market in 2018.
o Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 9.9% during the forecast period.

In 2018, North America accounted for the major share in the irritable bowel syndrome market size and is expected to continue this trend, owing to availability of well-developed infrastructure facilities, presence of majority of the key players, rise in gastrointestinal diseases, and huge availability of trained medical professionals. On the other hand, Asia-Pacific is estimated to register the fastest growth during the forecast period, owing to rise in disposable income, high population base, surge in the geriatric population, and increase in patient awareness toward irritable bowel syndrome treatment

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Irritable Bowel Syndrome Treatment Market to Hit $2,012 Mn by 2026 here

News-ID: 2005348 • Views: 66

More Releases from Allied Market Research

Brain Health Supplements Market – Know Latest Trends & Forecast for Long-Term …
UPDATE AVAILABLE ON-DEMAND Brain health supplements are balanced blend of herbal extracts and nutrients that are used to improve brain functions such as concentration, focus, and memory. The global brain health supplements market was valued at $3,194 million in 2016, and is expected to reach $5,813 million by 2023, growing at a CAGR of 8.8% from 2017 to 2023. Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/4581 Rise in awareness about brain health supplements, growth in number
Apheresis Market to High trend Opportunities offers Future Business Growth by 20 …
UPDATE AVAILABLE ON-DEMAND According to the report by Allied Market Research, the global Apheresis market is estimated to register a CAGR of 7.3% from 2017 to 2023. The research helps leading players and startups to devise new strategies based on current market trends and changing dynamics. Competitive landscape is mentioned in the report based on business segments, products portfolio, and strategic moves & developments of leading market players. Detailed segmentation assists
Medical Computer Carts Market New Business Opportunities and Investment Research …
UPDATE AVAILABLE ON-DEMAND According to the research report published by Allied Market Research, the global Medical Computer Carts market is expected to register a CAGR of 17.3% from 2017 to 2023. The research includes changing market dynamics, top impacting factors, key investment pockets, value chain, and competitive scenario. Through tabular and graphical representation, the report offers key insights on different aspects of the market such as current market size and estimations,
Medical Simulation Market Huge Demand in COVID-19: Regional Outlook, Trends, Key …
The Medical Simulation market report offers a comprehensive analysis of the study of the industry. The report provides the proper segmentation along with all the CAGR values for the forecast period 2020-2027. A wide range of features including the drivers, restraints, and future opportunities are also provided through the report. The report along with it also involves the analyses of rising trends and upcoming challenges in the market. The marketing

All 5 Releases


More Releases for Irritable

Irritable Bowel Syndrome Market Size, Share, Growth Rate, Segmentation, Trends a …
Los Angeles, United State, May 13, 2019, - The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Irritable Bowel Syndrome market. It sheds light on how the global Irritable Bowel Syndrome Market is expected to grow during the course of the forecast period. With SWOT analysis and Porter’s Five Forces analysis, it gives a deep explanation of the strengths and
Irritable Bowel Syndrome Drugs and Companies Research
Summary Irritable bowel syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. IBS is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least three months. IBS is classified into three main subtypes, according to the predominant bowel habit: constipation-predominant (IBS-C), diarrhea-predominant (IBS-D), and mixed-presentation (IBS-M) IBS. The IBS treatment landscape remains largely underserved, and
Irritable Bowel Syndrome Treatment Market Trends & Projection to 2022
Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome affects the large intestine. Irritable bowel syndrome is associated with malfunctioning of the bowel and majorly occurs in elder population. Constipation, diarrhea, abdominal pain, alteration and discomfort in bowel function and bloating are some of the common symptoms of irritable bowel syndrome. Blood test and endoscopy are normally performed
Irritable Bowel Syndrome Treatment Market to Surpass US$ 2,300 Million Threshold …
The global irritable bowel syndrome treatment market was valued at US$ 726.1 million in 2016 and is expected to witness a robust CAGR of 12.9% to reach US$ 2,300 Million over the forecast period (2017-2025). The Global Irritable Bowel Syndrome Treatment Market by drug type (lubiprostone, linaclotide, eluxadoline, rifaximin, alosetron, and others), medical condition (IBS-constipation and IBS-diarrhea), distribution channel (hospital pharmacies, online pharmacies, and retail pharmacies) and region (North America, Latin
Irritable Bowel Syndrome Treatment Market Forecasts, Trends and analysis 2023
A comprehensive analysis of the EMEA (Europe, Middle East and Africa) Irritable Bowel Syndrome Treatment Market is been done in this intelligence report. It includes the investigations done on the past progress, ongoing market scenarios, and future prospects. An accurate data of the products, strategies and market shares of leading companies in this particular market is mentioned. This report presents a 360-degree overview of the competitive scenario of the EMEA
Global Irritable Bowel Syndrome Treatment Market Professional Survey and Forecas …
"The Report Global Irritable Bowel Syndrome Treatment Market Professional Survey Report 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" This report studies Irritable Bowel Syndrome Treatment in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on